Trial Profile
A open, prospective study evaluating variability of Denosumab densitometric response in postmenopausal osteoporosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Oct 2018
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- 12 Oct 2018 New trial record